But a second could get the green light at the end of the month, after getting good results for treating melanoma, a particularly serious type of skin cancer. A genetically modified herpes virus, ...

A modified herpes virus (RP1) combined with immunotherapy showed promising results against advanced melanoma in a clinical ...

Longtime drug developer Suma Krishnan was 51 when she cofounded Krystal Biotech. Now the company has one gene therapy on the ...

Herpes is a systemic disease When herpes infection occurs, the virus not only goes into the sensory neurons and dorsal root ganglia, but it also gets into epidermal cells, lymphatics, and blood.

The idea that herpes infections trigger or contribute to Alzheimer's disease has been gaining favor among some scientists, ...

The treatment was safe and effective, with no detectable CRISPR-induced off-target cleavages or systemic adverse effects observed in all three patients for an average of 18 months.

The idea that herpes infections trigger or contribute to Alzheimer's disease has been gaining favor among some scientists, ...

Herpes simplex keratitis (HSK) is a common eye infection characterized by corneal damage, leading to opacity and visual impairment. The incidence of HSK is 10-30 per 100,000 in developed countries ...

2 Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report By Type (HSV-1, HSV-2), By Drug (Acyclovir, Valacyclovir, Famciclovir), By Vaccine (Simplirix, Others), By Route of ...

herpes simplex virus, cytomegalovirus, and Epstein-Barr virus in the semen of men attending an infertility clinic. Fertil Steril. 2003;79:1566-1570. 3.

RP1 is a herpes simplex virus, like T-VEC, but has been improved in numerous ways. In particular, it makes tumour cells fuse with neighbouring cells, helping the virus to spread through tumours ...